Dr Corinna Fiorotti

Dr. Corinna Fiorotti

Executive Director, Translational Sciences

The newest expert to join the Translational Sciences team, Dr. Corinna Fiorotti brings almost two decades of drug development experience in large pharma/biotech which spans from research through clinical development, with expertise in building and executing on strategies for bioanalytical development. Dr. Fiorotti holds a Ph.D. in Immunology and Microbiology and completed a post-doctoral fellowship in Molecular Biology at Harvard Medical School where her work was featured as a cover story in the journal Nature. Dr. Fiorotti has deep knowledge in immunogenicity and bioanalytical assays which cover a wide range of disease areas and therapeutic modalities including protein therapeutics, and cell and gene therapy. She has extensive expertise in cell-based assays in addition to developing ADA and PK assays for both pre-clinical and clinical support. Dr. Fiorotti has an exceptional track record working with project teams to identify the critical questions/decision points and delivering strategies to address them, leading to efficient prosecution of their programs. Dr. Fiorotti has a wide global footprint and is an invited speaker at bioanalytical focused meetings.

Dr. Corinna Fiorotti

Executive Director, Translational Sciences

The newest expert to join the Translational Sciences team, Dr. Corinna Fiorotti brings almost two decades of drug development experience in large pharma/biotech which spans from research through clinical development, with expertise in building and executing on strategies for bioanalytical development. Dr. Fiorotti holds a Ph.D. in Immunology and Microbiology and completed a post-doctoral fellowship in Molecular Biology at Harvard Medical School where her work was featured as a cover story in the journal Nature. Dr. Fiorotti has deep knowledge in immunogenicity and bioanalytical assays which cover a wide range of disease areas and therapeutic modalities including protein therapeutics, and cell and gene therapy. She has extensive expertise in cell-based assays in addition to developing ADA and PK assays for both pre-clinical and clinical support. Dr. Fiorotti has an exceptional track record working with project teams to identify the critical questions/decision points and delivering strategies to address them, leading to efficient prosecution of their programs. Dr. Fiorotti has a wide global footprint and is an invited speaker at bioanalytical focused meetings.

Dr Corinna Fiorotti